Neurodegeneration – News and Features

Researchers at the Weizmann Institute have found that Copaxone, originally developed for multiple sclerosis, may aid heart attack recovery. In animal studies, Copaxone improved heart function, reduced scar tissue, and protected heart muscle cells.

Researchers at Notre Dame developed an automated biochip that can diagnose glioblastoma in under an hour by detecting active EGFRs on extracellular vesicles from blood samples.

Boston University researchers developed an AI tool that accurately diagnoses 10 types of dementia, improving diagnosis accuracy by 26%. Using routine clinical data and MRI scans, the tool aids doctors in identifying dementia causes early.

Acute kidney injury is associated with an increased risk of developing dementia, according to a new study.

A McGill-led team of neuroscientists identified a third group of dopamine neurons that play a critical role in balancing brain functions related to movement, reward and cognition.

A new study highlights the potential cognitive benefits of cholinesterase inhibitor treatment in slowing cognitive decline in dementia with Lewy bodies.

In this interview, Jay Mandula describes his work in immuno-oncology, the challenges of being transgender in Florida and how increased visibility of LGBTQIA+ scientists can impact STEMM.

Newly developed highly energy-efficient, flexible nanogenerators demonstrate a 140-fold increase in power density when compared to conventional nanogenerators.

Researchers at Aarhus University are the first to identify the specific cell group in the brain that plays a central role in our ability to discriminate familiar and novel things, which is called recognition memory.

A study reveals that air pollution significantly increases ER visits for mental health disorders in historically redlined neighborhoods. Elevated pollutants like fine particulate matter is linked to higher risks of mental illness.